Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study

Authors: Ramaswamy, Krishna A | The Lancet. Oncology | June 25, 2024 | PubMed abstract

Explore all publications

Back To Top